The use of artificial intelligence to accelerate aging research, including drug discovery, biological age measurement, and disease prediction.

AI longevity refers to applying machine learning and large-scale data analysis to the biology of aging. Instead of testing one hypothesis at a time in a lab, AI models can scan patterns across genomics, proteomics, imaging, and clinical data to find signals researchers might otherwise miss.

In practice this shows up in a few areas: predicting biological age from blood or imaging data, screening molecules for anti-aging drug candidates, and modeling how cells behave as they age. None of this replaces clinical trials. It changes how fast researchers can generate and test hypotheses.

"AI longevity" is also used loosely in marketing, sometimes to describe a supplement app or wellness tracker with no real AI research behind it. The distinguishing question is whether AI is doing genuine pattern discovery on real data, such as drug discovery, biological age models, or clinical prediction, or just labeling a basic feature as "AI-powered."

Research publication: Definitions reflect current research status and are for educational purposes. This is not medical advice.